Kane Biotech
(TSXV) KNE
Kane Biotech Financials at a Glance
Market Cap
$5.46M
Revenue (TTM)
$574.87K
Net Income (TTM)
$1.95M
EPS (TTM)
$-0.01
P/E Ratio
-2.46
Dividend
$0.00
Beta (Volatility)
0.18 (Low)
Dividend
$0.00
Beta (Volatility)
0.18 (Low)
Price
$0.03
Volume
100,000
Open
$0.03
Price
$0.03
Volume
100,000
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.03 - $0.10
Dividend
$0.00
Beta (Volatility)
0.18 (Low)
Price
$0.03
Volume
100,000
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.03 - $0.10
KNE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kane Biotech
Industry
Biotechnology
Sector
Health CareCEO
Robert B. Huizinga, PhD
Website
www.kanebiotech.comHeadquarters
Winnipeg, MB R3T 6G2, CA
KNE Financials
Key Financial Metrics (TTM)
Gross Margin
-23%
Operating Margin
-5%
Net Income Margin
-3%
Return on Equity
0%
Return on Capital
-3%
Return on Assets
-71%
Earnings Yield
-40.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.46M
Shares Outstanding
181.85M
Volume
100.00K
Short Interest
0.00%
Avg. Volume
145.22K
Financials (TTM)
Gross Profit
$872.10K
Operating Income
$4.49M
EBITDA
$3.71M
Operating Cash Flow
$4.11M
Capital Expenditure
$24.74K
Free Cash Flow
$4.14M
Cash & ST Invst.
$358.81K
Total Debt
$2.29M
Kane Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.50K
-99.3%
Gross Profit
$41.35K
-107.4%
Gross Margin
-4.87%
N/A
Market Cap
$5.46M
N/A
Market Cap/Employee
$170.48K
N/A
Employees
32
N/A
Net Income
$607.35K
-0.3%
EBITDA
$499.26K
+12.0%
Quarterly Fundamentals
Net Cash
$1.36M
+21.8%
Accounts Receivable
$131.15K
-83.3%
Inventory
$339.00K
-50.8%
Long Term Debt
$1.68M
-8.6%
Short Term Debt
$621.55K
+38.7%
Return on Assets
-71.05%
N/A
Return on Invested Capital
-3.49%
N/A
Free Cash Flow
$698.22K
-27.7%
Operating Cash Flow
$698.22K
-29.7%